A psychologist has provided a deep dive into the crucial stages of dementia, offering guidance on how to recognise them in ...
It's important to understand that dementia isn't a single condition, but rather a broad term encompassing a range of symptoms ...
Previously lecanemab was only approved as an SC injection for maintenance dosing, following an initial 18 month IV phase.
A federal lawsuit accuses a CCRC of housing discrimination, saying that it used “unlawful, false stereotypes” in denying a ...
What are the differences in the brain between normal aging and a brain affected by the early stages of dementia? That is the discussion topic for the next program in a series presented by Wyoming ...
Stockhead on MSN
Health Check: Actinogen awaits crucial ‘futility’ ruling on Alzheimer’s disease trial
Actinogen Medical soon should find out whether its pivotal Xanamia Alzheimer's trial is futile, or hitting the right notes. .
4don MSN
Gut bacteria may be linked to memory decline in mild cognitive impairment and Alzheimer's disease
A comprehensive new review is shedding light on the growing evidence that gut microbiome imbalances—known as dysbiosis—may ...
A new resource is helping people with dementia speak to their doctors and health care professionals about their medicines with more confidence.
The Rutgers Robert Wood Johnson Medical School has been chosen as one of about 40 sites to see how well benfotiamine can slow ...
People often worry they will get Alzheimer’s disease if their parents did. But engaging in a healthy lifestyle can outweigh ...
LEQEMBI is currently approved in 53 countries and regions and is under regulatory review in 7 countries. In August 2025, the US FDA approved LEQEMBI IQLIK 360 mg for weekly subcutaneous maintenance ...
"Life is taken away from these children before they even have a chance to live it," says Megan Kempf of her two children, who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results